Biotherapeutic firm launches valley fever study
Prescott, Ariz. -- Imulan Biotherapeutics announced a study to test the effectiveness of a new immuno-therapeutic to treat dogs with coccidiodomycosis, or valley fever.
Prescott, Ariz.
-- Imulan Biotherapeutics announced a study to test the effectiveness of a new immuno-therapeutic to treat dogs with
coccidiodomycosis
, or valley fever.
Valley fever is an infection caused by the Coccidoides fungus and affects many species, including dogs and humans. The Southwest, specifically Arizona, is the primary area of infection in the United States.
The study will allow researchers to compare immunological vs. antifungal treatments in dogs to see how the treatments will work against human valley fever.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
